Wilhelm, A.D.* et al. Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients. Breast Cancer Res. 27:107 (2025)
Tollot-Wegner, M.* et al. TRPS1 maintains luminal progenitors in the mammary gland by repressing SRF/MRTF activity. Breast Cancer Res. 26:74 (2024)
Morra, A.* et al. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Res. 23:86 (2021)
Sanz-Moreno, A. et al. RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer. Breast Cancer Res. 23:42 (2021)
Penkert, J.* et al. Breast cancer patients suggestive of Li-Fraumeni syndrome: Mutational spectrum, candidate genes, and unexplained heredity. Breast Cancer Res. 20:87 (2018)
Quante, A.S. ; Whittemore, A.S.* ; Shriver, T.* ; Strauch, K. & Terry, M.B.* Breast cancer risk assessment across the risk continuum: Genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res. 14:R144 (2012)